SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007217
Filing Date
2022-05-04
Accepted
2022-05-04 10:01:49
Documents
80
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-20220331.htm   iXBRL 10-Q 2811595
2 EX-10.3 mcrb-ex10_3.htm EX-10.3 15650
3 EX-31.1 mcrb-ex31_1.htm EX-31.1 16693
4 EX-31.2 mcrb-ex31_2.htm EX-31.2 16566
5 EX-32.1 mcrb-ex32_1.htm EX-32.1 10367
6 EX-32.2 mcrb-ex32_2.htm EX-32.2 10327
  Complete submission text file 0000950170-22-007217.txt   9896666

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mcrb-20220331_cal.xml EX-101.CAL 61932
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20220331.xsd EX-101.SCH 67146
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20220331_def.xml EX-101.DEF 207055
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20220331_pre.xml EX-101.PRE 385500
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20220331_lab.xml EX-101.LAB 521458
74 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20220331_htm.xml XML 1806938
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 22890134
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences